Wolverine Trading’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,313
Closed -$361K 6268
2025
Q2
$302K Sell
3,313
-5,987
-64% -$470K ﹤0.01% 3465
2025
Q1
$857K Buy
+9,300
New +$807K ﹤0.01% 2396
2023
Q2
Sell
-339
Closed -$2.68K 5041
2023
Q1
$4K Buy
+339
New +$4.52K ﹤0.01% 4109
2022
Q2
Sell
-2,335
Closed -$158K 5855
2022
Q1
$240K Buy
+2,335
New +$260K ﹤0.01% 4180
2021
Q4
Sell
-799
Closed -$179K 6976
2021
Q3
$196K Buy
799
+250
+46% +$85.9K ﹤0.01% 5371
2021
Q2
$245K Buy
+549
New +$236K ﹤0.01% 4737

Other funds holding WGS

Wolverine Trading's WGS Position: Q3 2025 in Review

Wolverine Trading sold out of GeneDx Holdings (WGS) in Q3 2025, closing a stake of 3,313 shares — an estimated $361K sold.

Wolverine Trading first reported a position in WGS in Q2 2021 and held it in 6 quarters. The position peaked at $857K in Q1 2025. 268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

  • Wolverine Trading reported no remaining GeneDx Holdings position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 3,313 GeneDx Holdings shares in Q3 2025, an estimated $361K.
  • Wolverine Trading first reported a position in GeneDx Holdings in Q2 2021 and held it in 6 quarters.
  • Wolverine Trading's GeneDx Holdings position peaked at $857K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.